Today’s AI Is Already Changing Care for Cancer Patients
Today’s AI Is Already Changing Care for Cancer Patients
https://spectrum.ieee.org/can-ai-cure-cancer-javorsky
Publish Date: 2026-05-05 08:00:01
Source Domain: spectrum.ieee.org
The article discusses the ambitious goals set by major tech firms like Meta and OpenAI to develop powerful, versatile AI technologies, including artificial general intelligence (AGI) and even more capable artificial super intelligence (ASI). Despite the billions of dollars invested in this area, Emilia Javorsky, director of the Futures program at the Future of Life Institute, cautions against the over-hyped promises of AI, particularly artificial super intelligence, in solving major global issues like curing cancer. Javorsky argues that cancer is a highly individualized disease, and achieving a universal cure is impractical. She emphasizes that promising uses of existing AI technologies are already making headway in personalized medicine, cancer detection, clinical trial optimization, and developing biomarkers for diseases. The focus, according to Javorsky, should be on leveraging mature AI solutions and addressing gaps in healthcare infrastructure and data collection instead of overinvesting in ASI research, which is speculative and lacks empirical backing.
Javorsky’s essay seeks to balance optimism and pragmatism, advocating for a realistic approach towards health data collection, improved measurement tools, and strategic investment in current AI advancements. She proposes a multi-pronged plan that includes scaling AI tools that are already effective in oncology, investing in biological research areas, and addressing institutional and systemic bottlenecks in medical progress.
Key Points:
– Large investments in AGI and ASI may divert resources from proven AI applications.
– Current AI technologies are making significant strides in cancer personalization, detection, and trials.
– Overinvestment in superintelligent AI may not be the most pragmatic approach.
– Emphasizing the right types of AI and addressing data collection in healthcare is crucial.
– A balanced approach focuses on existing AI advancements, biology-related research, and overcoming healthcare bottlenecks.
